Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin SR vs Clarithromycin ER in Mild to Moderate CAP
NCT00643227Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 3, randomised, double-blind trial of azithromycin in community acquired pneumonia (CAP) (2 arms), sponsored by Pfizer. Primary endpoint: Sponsor Assessment of Clinical Response (Clinical Cure Rate). Started Jan 2003; status: completed.
02
Drugs
azithromycin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT00643227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00643227.